ArticleScientific reports2025
Axial elongation among Hong Kong myopic children and adolescents wearing single vision spectacles from a clinical setting.
Article in Scientific reports, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 1 paper.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
1 citing paper in PubMed.
- Association Between Pupil Area and the Efficacy of Peripheral Defocus Spectacle Lenses in Myopia Control.Translational vision science & technology · 2026Article
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
3 authors.
Funding
Abstract
This retrospective cohort study investigates axial elongation in myopic children and adolescents wearing single vision spectacles, before and after the availability of proven myopia control spectacles. Electronic clinical records of patients aged 3-17 years who were prescribed single vision spectacle lenses between July 2012 and August 2013 (2012_13 cohort) and between July 2018 and August 2019 (2018_19 cohort) were analyzed. Follow-up duration ranged from 12 to 51 months, and axial elongation was normalized to a 12-month change. There were 330 and 165 patients in the 2012_13 and 2018_19 cohorts, respectively. The annualized axial elongation, expressed as mean (standard error), was 0.27 (0.01) mm for the 2012_13 cohort and 0.26 (0.01) mm for the 2018_19 cohort. In both cohorts, median annual axial growth was ≥ 0.40 mm at ages 3-5, ≥ 0.30 mm at ages 6-8, ≥ 0.20 mm at ages 9-10, ≥ 0.10 mm at ages 11-13, and < 0.10 mm at ages 14-17. Younger age was closely associated with faster annualized axial elongation, with each year of increase in baseline age results in a decrease in annualized axial growth by 0.04 mm. These findings serve as a useful reference for future myopia control trials to assess treatment efficacy.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.